Basanite Valuation

Is BASA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BASA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate BASA's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate BASA's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for BASA?

Key metric: As BASA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for BASA. This is calculated by dividing BASA's market cap by their current revenue.
What is BASA's PS Ratio?
PS Ratio38.9x
SalesUS$267.61k
Market CapUS$10.41m

Price to Sales Ratio vs Peers

How does BASA's PS Ratio compare to its peers?

The above table shows the PS ratio for BASA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.6x
ADMT ADM Tronics Unlimited
1.7xn/aUS$5.4m
GURE Gulf Resources
0.5xn/aUS$6.7m
GLGI Greystone Logistics
0.5xn/aUS$27.7m
BSLK Bolt Projects Holdings
7.7xn/aUS$11.5m
BASA Basanite
38.9xn/aUS$10.4m

Price-To-Sales vs Peers: BASA is expensive based on its Price-To-Sales Ratio (38.9x) compared to the peer average (2.6x).


Price to Sales Ratio vs Industry

How does BASA's PS Ratio compare vs other companies in the US Chemicals Industry?

10 CompaniesPrice / SalesEstimated GrowthMarket Cap
TSE Trinseo
0.04x5.0%US$125.68m
ALTO Alto Ingredients
0.1x3.1%US$108.84m
BON Bon Natural Life
0.2xn/aUS$6.23m
ABLT American Biltrite
0.02xn/aUS$2.91m
BASA 38.9xIndustry Avg. 1.4xNo. of Companies17PS01.22.43.64.86+
10 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: BASA is expensive based on its Price-To-Sales Ratio (38.9x) compared to the US Chemicals industry average (1.4x).


Price to Sales Ratio vs Fair Ratio

What is BASA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BASA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio38.9x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate BASA's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies